Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab

Fibrolamellar carcinoma (FLC) is a rare cancer of the liver that most commonly affects children and young adults. There is no clear standard of care for the disease, whose response to treatment seems to be very different from that of hepatocellular carcinoma. We present a case of FLC in a patient in...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Raanan, Dinstag, Gal, Tirosh, Omer, Schiff, Eyal, Kleiner, David, Aldape, Kenneth D, Ruppin, Eytan, Beker, Tuvik, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743402/
https://www.ncbi.nlm.nih.gov/pubmed/36600603
http://dx.doi.org/10.1136/jitc-2022-005620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743402/
https://www.ncbi.nlm.nih.gov/pubmed/36600603
http://dx.doi.org/10.1136/jitc-2022-005620

Ejemplares similares